 Today I have the pleasure of speaking with David Regan from Sono Nanotech. How are you today David? I'm well Tracy, great to be here. It's my understanding that Sono Nanotech is in essence the gold standard for nanotech. Can you tell us why? We're the gold standard for nanotechnology because we have unique biocompatible gold nanorods that have a wide variety of applications in medical applications and others. Let's hit the ground running shall we David? The first thing I want to ask you is your partnership down in the USA. You've got something in front of the FDA is that correct? We've partnered with a company in the US that's FDA certified and we are working to get an application in with them to the FDA for an emergency use application for a COVID saliva test yes. And of course why is this a competitive application? Hit our investors with the highlights. So there still isn't a rapid saliva COVID test. We've heard many people saying look yes Omicron presents first in saliva that's really what we ought to be using. There's research out there on that and of course we all know they're going to be sadly further waves to this pandemic. And of course all of you medtech fans out there that are looking for a moonshot potential in your portfolio this upcoming year. Can you tell us some other reasons and applications why Sona nanotech is a company that all investors should embark on doing their due diligence on now? Our COVID rapid saliva test gets all the attention but there's proprietary technology in the company that has far-reaching potential and something that we're undertaking research on with with University of Toronto and one of the top researchers into nanotechnology. We think can yield key key developments for nanotechnology and medical applications worldwide. Speaking of key developments you've just basically announced two very impressive board members. Can you give us some highlights on these individuals please? Sure Tracy we're very very pleased to welcome to the board firstly a senior scientist with background with NASDAQ listed biotechs, brings a lot to the table, Columbia Masters and PhD. Also the Canadian longtime Canadian president of Medtronics a global leader in medical devices. I think this is validation for the company and the belief in the potential for not just the current tests we're working on but the underlying technology in the future of the company. Oftentimes I ask the CEO what we should anticipate in the upcoming quarter but I'm not going to ask that of you today David what I'm going to do instead is have you back on in four weeks can we make that commitment? I'd be very happy to do that we've got a lot of work going on right now. Some very exciting things on on multiple fronts for the company and we look forward to having some announcements in the future and being able to dig in with you Tracy. If you'd like more information on this company please send it to this email address. Thank you David for joining us today. Thank you Tracy appreciate it.